Short Interest in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Grows By 27.3%

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 6,520,000 shares, a growth of 27.3% from the February 28th total of 5,120,000 shares. Based on an average trading volume of 1,880,000 shares, the short-interest ratio is currently 3.5 days. Currently, 7.2% of the company’s shares are sold short.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Mizuho dropped their price objective on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 25th. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $43.00 to $35.00 in a report on Friday, February 28th. TD Cowen dropped their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Bank of America reduced their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $52.19.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $29.93 on Wednesday. Acadia Healthcare has a 12 month low of $27.61 and a 12 month high of $82.41. The stock has a fifty day moving average price of $36.58 and a 200-day moving average price of $44.16. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.78 billion, a PE ratio of 9.81, a P/E/G ratio of 1.46 and a beta of 1.38.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently added to or reduced their stakes in ACHC. Cerity Partners LLC raised its position in shares of Acadia Healthcare by 43.7% in the 3rd quarter. Cerity Partners LLC now owns 32,922 shares of the company’s stock valued at $2,088,000 after purchasing an additional 10,019 shares during the last quarter. Glenmede Trust Co. NA raised its holdings in shares of Acadia Healthcare by 40.2% in the third quarter. Glenmede Trust Co. NA now owns 5,327 shares of the company’s stock worth $338,000 after buying an additional 1,528 shares during the last quarter. Verition Fund Management LLC acquired a new stake in shares of Acadia Healthcare during the third quarter worth $382,000. Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of Acadia Healthcare by 193.1% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,541 shares of the company’s stock valued at $161,000 after buying an additional 1,674 shares during the last quarter. Finally, Clearline Capital LP raised its stake in Acadia Healthcare by 27.7% in the 3rd quarter. Clearline Capital LP now owns 211,332 shares of the company’s stock worth $13,401,000 after acquiring an additional 45,816 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.